The present invention relates to a compound represented by Formula I, a racemate or optical isomer thereof, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof, a pharmaceutical composition comprising the compound, and a use thereof in the manufacture of a medicament for preventing and/or treating a disease or disorder associated with a viral infection.
本发明涉及一种由式 I 代表的化合物、其外消旋物或光学异构体、或其药学上可接受的盐、溶液或
水合物、包含该化合物的药物组合物,以及其在制造预防和/或治疗与病毒感染有关的疾病或紊乱的药物中的用途。